The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Memantine And Donepezil Hydrochlorides
Memantine And Donepezil Hydrochlorides · MEMANTINE HYDROCHLORIDE 21 mg/1; DONEPEZIL HYDROCHLORIDE 10 mg/1 · Capsule, Extended Release · Oral · ANI Pharmaceuticals, Inc.
NDC 62559-0207-30 · 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$14.86per unit
middle half $14.41–$16.77 · 2,312 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $14.86
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
42%of plans cover it
tier 3 · prior auth 58% · step therapy 1% · qty limit 44%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 5 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$565.44
Reported to Texas DSHS · 2026 annual filing · ANIP Acquisition Company
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$25,439
43 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA208237
- TE code
- AB
- Approval date
- Dec 15, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Memantine And Donepezil Hydrochlorides (Capsule, Extended Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| ANI Pharmaceuticals, Inc. | MEMANTINE HYDROCHLORIDE 21 mg/1; DONEPEZIL HYDROCHLORIDE 10 mg/1 | Aug 26, 2026 | Sep 2, 2026 |
| ANI Pharmaceuticals, Inc. | MEMANTINE HYDROCHLORIDE 10 mg/1; DONEPEZIL HYDROCHLORIDE 21 mg/1 | Jul 22, 2026 | Aug 19, 2026 |
| ANI Pharmaceuticals, Inc. | DONEPEZIL HYDROCHLORIDE 10 mg/1; MEMANTINE HYDROCHLORIDE 21 mg/1 | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Memantine And Donepezil Hydrochlorides — NDC 62559-0207-30," retrieved September 3, 2026, https://drugdashboards.com/drug/62559020730.
Free to cite with attribution — see how the data is put together.